Cetrorelix acetate equivalent to

Cetrorelix 250 mcg
Excipients q.s.
After reconstitution with the Diluent Sterile Water for Injection, each mL of the solution contains 0.25 mg cetrorelix.

Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

In clinical trials Cetrorelix was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicle-stimulating hormone (FSH) suggested similar efficacy.

Please consult your physician for personalized medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition or treatment before undertaking a new healthcare regimen. This product brief is not an advertisement and is not intended to be a substitute for a professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it. If symptoms persist, consult your physician.